Report on Dengvaxia mess up for plenary discussion, says Gordon | Inquirer News

Report on Dengvaxia mess up for plenary discussion, says Gordon

/ 07:29 AM April 28, 2018

Sen. Richard Gordon. INQUIRER.net PHOTO/CATHY MIRANDA

The blue ribbon committee report on the Senate inquiry into the Aquino administration’s purchase of the dengue vaccine Dengvaxia can now be tackled in the plenary after it was signed by a majority of senators, Sen. Richard Gordon said on Friday.

Gordon said in a statement that 13 of his colleagues in the 24-member Senate had signed the report.

Article continues after this advertisement

They are Senators JV Ejercito, Vicente Sotto III, Gregorio Honasan, Juan Miguel Zubiri, Sonny Angara, Nancy Binay,  Sherwin Gatchalian, Grace Poe, Francis Escudero, Manny Pacquiao, Ralph Recto, Cynthia Villar and Loren Legarda, he said.

FEATURED STORIES

The draft report found former President Benigno Aquino III, former Health Secretary Janette Garin and former Budget Secretary Florencio Abad, among others, liable for violating the antigraft law for the purchase and distribution of Dengvaxia.

Controversial program

Article continues after this advertisement

The government’s dengue vaccination program became controversial after Dengvaxia’s French manufacturer, Sanofi Pasteur, said earlier this year that the use of the vaccine could cause more severe dengue symptoms in people who have not contracted the disease before.

Article continues after this advertisement

Gordon said he was happy the report could be tackled on the Senate floor.

Article continues after this advertisement

“With 14 senators signing the report, I am happy that it will be discussed on the floor finally where it should be discussed. I recognize that not all of my colleagues agree with the report but I am willing to debate and discuss it on the floor,” he said.

No conclusive evidence

Article continues after this advertisement

Earlier, Senate Minority Leader Franklin Drilon, an ally of the former President, objected to Gordon’s findings.

According to Drilon, he found no conclusive evidence to support the contention that the reported deaths of young students who were inoculated with Dengvaxia were connected to the use of the vaccine. The matter should be studied by qualified pathologists, he said. —LEILA B. SALAVERRIA

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Blue Ribbon, dengue, Dengvaxia, Senate

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.